Selegiline, a monoamine oxidase (MAO) inhibitor, was invented by Zoltan Ecseri at the Hungarian pharma company. Many years later, in 1989, it got the first FDA approvalÂ for the treatment of depression.

**FDA-approved-Indications**

- Adjunct treatment in the management of patients with Parkinson disease

- Treatment for a major depressive disorder (MDD) in adults

**Off-label Uses**

- Treatment for early Parkinson disease

- Treatment of attention-deficit/hyperactivity disorder (ADHD)